Qays_Kayson

Qays_Kayson

Bitcoin - buying opportunity on the horizon. "Crypto assets have been around for more than a decade, but it’s only now that efforts to regulate them have moved to the top of the policy agenda. This is partly because it’s only in the past few years that crypto assets have moved from being niche products in search of a purpose to having a more mainstream presence...

Qays_Kayson

NETLIX any further down ? What do you think ? after all this news about Netflix, do you think the company will witness more loses ?

Qays_Kayson

I think it is a chance to buy EURUSD (not to sell) as long as the pair is above 1.08. This also to be confirmed, if the pair closes the weekly above 1.0820 and NOT below 1.078 as a weekly close. Ich glaube, das Paar wird steigen. Es ist also eine Chance zu kaufen, nicht zu sel, solange das Paar höher als 1,08 ist. Dies wird bestätigt, wenn der Wochenschluss höher...

Qays_Kayson

Wheat Price hit 2008 financial crises high. the consequences of the Russian-Ukraine, in addition to the fact that the world economy has been already suffering for the Covid19 economic consequences "like inflation and increase in shipping price, wheat prices are now hitting 2008 financial crises highs.

Qays_Kayson

Risk of Severe hunger if supply chains disrupted with threat of a Russian invasion of Ukraine.

Qays_Kayson

I still believe USDILS will pullback soon from 3.21 to 3.1360

Qays_Kayson

it is expected that the pair will test 3.1370 gain before it bounce again to a new resistant point. This time however, the new resistant point is 3.1860

Qays_Kayson

the Bitcoin will continue its downward phase toward 27,200 When the real economy is facing inflation, then people need more liquidity on real currencies.

Qays_Kayson

EURUSD next target is 1.16 and then we have another target

Qays_Kayson

great chance to buy based on technical analyst purely

Qays_Kayson

USDILS seems to be standing just on a one year year trendline. Ich glaube, that if this trendline was broken either above of its current level ( 3.165ish) oder it will continue at its downtrend

Qays_Kayson

The CSI 300 (Chinese) is a capitalization-weighted stock market index designed to replicate the performance of the top 300 stocks traded on the Shanghai Stock Exchange and the Shenzhen Stock Exchange. It has two sub-indexes: the CSI 100 Index and the CSI 200 Index. Over the years, it has been deemed the Chinese counterpart of the S&P 500 index and a better gauge...

Qays_Kayson

DXY Technical, but also supported by FED expectation to raise Interest rates or at lease speeding up the end of its pandemic-era bond purchase, this how te DXY would look like.

Qays_Kayson

I still believe that the EURUSD shall hit 1.0830. BUT on its way down there is a possible to correct toward 1.16.

Qays_Kayson

Israeli Shekel Outlook: Technical Analysis point of view: In my opinion and based on Fib. Retracement and trend, I believe the pair will start correcting up toward these targets: T1: 3.23, if broken up then: T2: 3.35, if broken up then, T3: 3.46 however, the pair would ultimately the price will continue on its downtrend.

Qays_Kayson

Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.

Qays_Kayson

The Lion Electric Co is a manufacturer of zero-emission vehicles. It creates, designs and manufactures all-electric class 5 to class 8 commercial urban trucks and all-electric buses and minibuses for the school, paratransit and mass transit segments. Lion is a North American company engaged in electric transportation and designs, builds and assembles all its...

Qays_Kayson

OCUGEN do you think it will go up ugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa,...